---
title: Designing and Monitoring Anti-NGF Imaging Endpoints
description: Members of our group have substantial experience in imaging in osteoarthritis and NGF-targeting therapies affected joints in a similar manner.
image: https://www.thebrackengroup.com/hubfs/Blog%20Headers%20(39).png
---

[![logo](https://www.thebrackengroup.com/hubfs/TBG/Images/logo.svg) ](https://www.thebrackengroup.com/)

- Our Services & Expertise 
    - Consulting 
          - [Consulting Overview](https://www.thebrackengroup.com/expertise-overview)
          - [Clinical Trial Strategy & Operations](https://www.thebrackengroup.com/clinical-trial-strategy)
          - [Medical Imaging Strategy & Operations](https://www.thebrackengroup.com/medical-imaging-clinical-trials)
          - [Radiopharmaceutical Strategy & Operations](https://www.thebrackengroup.com/radiopharmaceuticals)
          - [Mergers & Acquisitions Advisory](https://www.thebrackengroup.com/mergers-and-acquisitions-due-diligence)
          - [Musculoskeletal Services](https://www.thebrackengroup.com/musculoskeletal-services)
          - [Neuroscience Expertise](https://www.thebrackengroup.com/neuroscience)
          - [Functional Service Provider](https://www.thebrackengroup.com/functional-service-provider)
          - [Consultant Publications](https://www.thebrackengroup.com/publications)
    - [Regulatory Affairs](https://www.thebrackengroup.com/regulatory) 
          - [FDA Meeting Request Calculator](https://www.thebrackengroup.com/fda-meeting-calculator)
    - [Creative Digital Marketing](https://www.thebrackengroup.com/creative-digital-marketing-strategy)
    - [Data & Analytics](https://www.thebrackengroup.com/custom-analytics) 
          - [Bracken CRM Add-On](https://www.thebrackengroup.com/bracken-crm)
          - [Bracken CRM Add-On Demos](https://www.thebrackengroup.com/analytics-demos)
- [Our Team](https://www.thebrackengroup.com/team)
- [Our Values](https://www.thebrackengroup.com/our-values)
- Our Media 
    - [Events & Conferences](https://www.thebrackengroup.com/upcoming-events)
    - [Case Study Library](https://www.thebrackengroup.com/case-studies)
    - [Blog](https://www.thebrackengroup.com/blog) 
          - [Infographics](https://www.thebrackengroup.com/infographics)
    - [Interactive Digital Tools](https://www.thebrackengroup.com/interactive-digital-tools)
    - [FDA Meeting Request Calculator](https://www.thebrackengroup.com/fda-meeting-calculator)
    - [Thought Leadership](https://www.thebrackengroup.com/thought-leadership)
    - [Radiopharma Roundtables](https://www.thebrackengroup.com/radiopharma-roundtable-series)
    - [Fractals: Our Podcast](https://www.thebrackengroup.com/fractals-podcast)
    - [The Leaflet: Our Newsletter](https://www.thebrackengroup.com/the-leaflet-newsletter)
- [Contact Us](https://www.thebrackengroup.com/contact)

[![](https://www.thebrackengroup.com/hubfs/The%20Bracken%20Group/Combined%20Shape.png)  Back](https://www.thebrackengroup.com/case-studies-home)

 11 June 2018

# Designing and Monitoring Anti-NGF Imaging Endpoints

Written by [Colin G. Miller](https://www.thebrackengroup.com/case-studies/author/coling-miller)

![](https://www.thebrackengroup.com/hubfs/Blog%20Headers%20(39).png)

**Problem**

Anti-nerve growth factor (NGF) therapeutics are a new class of powerful analgesics in clinical development. But the FDA put their clinical development on hold in 2012 because joint destruction was observed in a small subset of patients. Pfizer, the leading developer of NGF compounds, needed a way to evaluate all major joints in subjects entering the new Phase III program.

**Solution**

Members of our group have substantial experience in imaging in osteoarthritis and NGF-targeting therapies affected joints in a similar manner, so Pfizer specifically sought us out. The solution was to:

- Engage a team of radiologists to develop a new radiographic technique to evaluate the joints in the defined patient population.
- Build and participate in a strong academic team that published a landmark [Imaging Atlas](https://www.oarsijournal.com/article/S1063-4584(14)01247-3/abstract) in 2015. The book described the technique and now serves as a key clinical reference.
- Further develop specific inter-reader training and validation techniques to reduce variability in this new arena.  The first reproducibility paper from this study has already been published.

**Outcome**

Pfizer conducted a very successful anti-NGF program with all the radiological and MRI reads done in a reproducible and effective manner.

- [Imaging Atlas - OARSI](https://www.oarsijournal.com/article/S1063-4584(14)01247-3/abstract)
- [Imaging Atlas - *Science Direct* - Part I](https://www.sciencedirect.com/science/article/pii/S1063458414012618)
- [Imaging Atlas - *Science Direct *- Part II](https://www.sciencedirect.com/science/article/pii/S1063458414012606)
- [Imaging Atlas - *Science Direct* - Part III](https://www.sciencedirect.com/science/article/pii/S1063458414012643)
- Reproducibility paper
- Pfizer anti-NGF programs
  
    - [NCT02528253](https://clinicaltrials.gov/ct2/show/NCT02528253)
    - [NCT02528188](https://clinicaltrials.gov/ct2/show/NCT02528188)
    - [NCT02725411](https://clinicaltrials.gov/ct2/show/NCT02725411)
    - [NCT02709486](https://clinicaltrials.gov/ct2/show/NCT02709486)
    - [NCT02674386](https://clinicaltrials.gov/ct2/show/NCT02674386)

[Click here to open a PDF version of this case study.](https://www.thebrackengroup.com/hubfs/Blog%20Post%20Images/TBG%20Case%20Study%20-%20Designing%20and%20Monitoring%20Anti-NGF%20Imaging%20Endpoints.pdf)

 

[![New call-to-action](https://no-cache.hubspot.com/cta/default/4628766/ced569ef-805e-4e07-a15f-5478c1ff39d8.png)](https://cta-redirect.hubspot.com/cta/redirect/4628766/ced569ef-805e-4e07-a15f-5478c1ff39d8)

 RECENT CASE STUDIES

[View All  ![](https://www.thebrackengroup.com/hubfs/The%20Bracken%20Group/Combined%20Shape.png)](https://www.thebrackengroup.com/case-studies)

<https://www.thebrackengroup.com/case-studies/embedding-patient-engagement-into-clinical-development>

 3 June 2026

#### [Embedding Patient Engagement into Clinical Development](https://www.thebrackengroup.com/case-studies/embedding-patient-engagement-into-clinical-development)

 The Scenario A global, mid-sized biopharmaceutical company had made PFDD a strategic priority and..

<https://www.thebrackengroup.com/case-studies/embedding-patient-engagement-into-clinical-development>

<https://www.thebrackengroup.com/case-studies/the-imaging-rescue-study-stepping-in-mid-trial-to-rescue-a-phase-3-oncology-study>

 28 May 2026

#### [The Imaging Rescue Study: Stepping in Mid-Trial to Rescue a Phase 3 Oncology Study](https://www.thebrackengroup.com/case-studies/the-imaging-rescue-study-stepping-in-mid-trial-to-rescue-a-phase-3-oncology-study)

 The Scenario: A global healthcare and technology company needed an expert review of how medical..

<https://www.thebrackengroup.com/case-studies/the-imaging-rescue-study-stepping-in-mid-trial-to-rescue-a-phase-3-oncology-study>

![logo](https://www.thebrackengroup.com/hubfs/TBG/Images/logo.svg)

###### [CONTACT](https://www.thebrackengroup.com/case-studies/2018/6/11/designing-and-monitoring-anti-ngf-imaging-endpoints#)

The Bracken Group   
12 Penns Trail   
Newtown, PA 18940

- [ + 1 215 648 1208 ](tel:+12156481208)
- [ info@thebrackengroup.com ](mailto:info@thebrackengroup.com)

###### [SUBSCRIBE TO OUR NEWSLETTER: THE LEAFLET](https://www.thebrackengroup.com/the-leaflet-newsletter)

###### [SCHEDULE A CALL](https://meetings.hubspot.com/allyson-pauly)

- [ LINKEDIN ](https://www.linkedin.com/company/the-bracken-group)

- Services 
    - [C-suite](https://www.thebrackengroup.com/functional-service-provider)
    - [Regulatory](https://www.thebrackengroup.com/regulatory)
    - [Creative Digital Marketing](https://www.thebrackengroup.com/creative-digital-marketing-strategy)
    - [Custom Analytics](https://www.thebrackengroup.com/custom-analytics)
    - [Consulting](https://www.thebrackengroup.com/expertise-overview)
- Solutions 
    - [Bracken CRM](https://www.thebrackengroup.com/bracken-crm)

- Media 
    - [Blog](https://www.thebrackengroup.com/blog)
    - [Case Studies](https://www.thebrackengroup.com/case-studies)
    - [Resources](https://www.thebrackengroup.com/en/resources-landing)
    - [The Leaflet](https://www.thebrackengroup.com/the-leaflet-newsletter)

- Ecosystem 
    - [Our Team & Story](https://www.thebrackengroup.com/team)
    - [Careers](https://www.thebrackengroup.com/career)
    - [Contact](https://www.thebrackengroup.com/contact)

![](https://www.thebrackengroup.com/hubfs/The%20Bracken%20Group/TBG%20Logo.png)

###### It's almost like getting free consulting...

Subscribe to our monthly hand-crafted newsletter for the latest insights on clinical trial trends and the life science industry.

[Subscribe Now  ![](https://www.thebrackengroup.com/hubfs/The%20Bracken%20Group/Combined%20Shape.png)](https://www.thebrackengroup.com/newsletter)

12 Penns Trail, Newtown, PA 18940  
[+1 215 648 1208](tell:+12156481208)

© 2026 the bracken group - [Privacy Policy](https://thebrackengroup-4628766.hs-sites.com/privacy-policy)

- EXPERTISE 
    - [Overview](https://www.thebrackengroup.com/expertise-overview)
    - [Virtual C-Suite](https://www.thebrackengroup.com/functional-service-provider)
    - [Due Diligence Support](https://www.thebrackengroup.com/mergers-and-acquisitions-due-diligence)
    - [Medical Imaging in Clinical Trials](https://www.thebrackengroup.com/medical-imaging-clinical-trials)
    - [Regulatory Strategy & Implementation](https://www.thebrackengroup.com/regulatory)
    - [Clinical Trial Strategy](https://www.thebrackengroup.com/clinical-trial-strategy)

- RESOURCES 
    - [Blog](https://www.thebrackengroup.com/blog)
    - [Case Studies](https://www.thebrackengroup.com/case-studies)
    - [Newsletter](https://www.thebrackengroup.com/newsletter)

- ABOUT US 
    - [The Bracken Team](https://www.thebrackengroup.com/team)

- SUPPORT 
    - [Contact Us](https://www.thebrackengroup.com/contact)
    - [Schedule a Call](https://www.thebrackengroup.com/contact)
    - [Terms of Service](https://www.thebrackengroup.com/privacy-policy)

12 Penns Trail, Newtown, PA 18940  
[+1 215 648 1208](tell:+12156481208)

© 2026 the bracken group - [Privacy Policy](https://thebrackengroup-4628766.hs-sites.com/privacy-policy)

[![The Bracken Group](https://www.thebrackengroup.com/hubfs/TBG/Images/logo.svg) ](https://www.thebrackengroup.com)

Consulting, creative/digital marketing, and data analytics for life science and digital health companies.

#### Services

- [Consulting](https://www.thebrackengroup.com/expertise-overview)
- [Regulatory Affairs](https://www.thebrackengroup.com/regulatory)
- [Fractional C-Suite](https://www.thebrackengroup.com/functional-service-provider)
- [Creative / Digital Marketing](https://www.thebrackengroup.com/creative-digital-marketing-strategy)
- [Data & Analytics](https://www.thebrackengroup.com/custom-analytics)

#### Explore

- [Our Team](https://www.thebrackengroup.com/team)
- [Fractals: Our Podcast](https://www.thebrackengroup.com/fractals-podcast)
- [Case Studies](https://www.thebrackengroup.com/case-studies)
- [Publications](https://www.thebrackengroup.com/publications)

#### Connect

 The Bracken Group  
 12 Penns Trail, Newtown, PA 18940  
[+1 215 648 1208](tel:+12156481208) 

[Contact us →](https://www.thebrackengroup.com/contact) [LinkedIn ](https://www.linkedin.com/company/thebrackengroup/)

© 2026 The Bracken Group dba Bracken Data, Inc. · All rights reserved. [Privacy Policy](https://thebrackengroup-4628766.hs-sites.com/privacy-policy)